Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4268221

CC(C)(C)Nc1nc2nonc2nc1-c1ccc(Cl)c(Cl)c1.N

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.51
HTT P42858 3/20 0.51
POLB P06746 3/20 0.51
CNR1 P21554 1/20 0.37
GLP1R P43220 1/20 0.35
MAPT P10636 4/20 0.34
TP53 P04637 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
CCR2 P41597 1/20 0.34
CCR5 P51681 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
AHR P35869 1/20 0.33
NR1H4 Q96RI1 1/20 0.33
NOTUM Q6P988 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL4262055 0.87 LMNA (0.36) LMNAHTTPOLBMAPTTP53
Ammonia Solution, Strong SCHEMBL4275960 0.78 MAPT (0.46) LMNAHTTPOLBMAPTTP53
Ammonia Solution, Strong SCHEMBL4262504 0.78 KDM4E (0.39) HTTPOLBMAPTTP53MAPK1
SCHEMBL3052187 0.77 HTT (0.57) LMNAHTTPOLBMAPTTP53
Ammonia Solution, Strong SCHEMBL4262241 0.71 GUSB (0.49) HTTMAPTTP53SMN1; SMN2CCR2
Ammonia Solution, Strong SCHEMBL4267150 0.70 HDAC4 (0.38) LMNAMAPTMAPK1NR1H4ALDH1A1
Ammonia Solution, Strong SCHEMBL4265881 0.69 POLB (0.31) POLBNR1H4
Ammonia Solution, Strong SCHEMBL4270918 0.69 TUBB4A (0.48) HTTPOLBMAPTTP53SMN1; SMN2
SCHEMBL3051396 0.66 TP53 (0.55) LMNAHTTPOLBMAPTTP53
Ammonia Solution, Strong SCHEMBL4262270 0.66 MAPT (0.53) LMNAHTTPOLBMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090131445-A1 Furazano '3, 4-B! Pyrazines and Their Use as Anti-Tumor Agents COMPASS PHARMACEUTICALS LLC (US) 2009-05-21 US claimed
US-20090131445-A1 Furazano '3, 4-B! Pyrazines and Their Use as Anti-Tumor Agents COMPASS PHARMACEUTICALS LLC (US) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131445-A1 Furazano '3, 4-B! Pyrazines and Their Use as Anti-Tumor Agents CDC73, RB1, CA5A LMNA 1452/4885HTT 4435/4885POLB 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.